STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal spray that may cause “adverse” effects. The NasoGel was recalled by the ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...